+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Proair"

Bronchodilators Market Report 2025 - Product Thumbnail Image

Bronchodilators Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
  • 6 Results (Page 1 of 1)
Loading Indicator

ProAir is a brand of respiratory drugs used to treat and prevent airway spasms in people with asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders. ProAir is a type of short-acting beta-agonist (SABA) bronchodilator, which works by relaxing the muscles in the airways to improve breathing. It is available in both inhaler and nebulizer forms, and is typically used to provide quick relief from symptoms such as wheezing, chest tightness, and shortness of breath. ProAir is one of many respiratory drugs on the market, and is often used in combination with other medications to treat and prevent airway spasms. Other types of respiratory drugs include long-acting beta-agonists (LABAs), inhaled corticosteroids (ICS), and leukotriene modifiers. Some companies that produce ProAir and other respiratory drugs include GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more